Literature DB >> 25955082

Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays.

D Provaznikova1, K Houskova1, A Radovska1, P Salaj2, I Hrachovinova1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25955082     DOI： 10.1111/hae.12705

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

Review 1.  Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B.

Authors:  Richard A Marlar; Karin Strandberg; Midori Shima; Dorothy M Adcock
Journal:  Eur J Haematol       Date:  2019-11-13       Impact factor: 2.997

2.  The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?

Authors:  Lisette M Schütte; Luca S Hodes; Iris van Moort; Sara C M Stoof; Frank W G Leebeek; Marjon H Cnossen; Moniek P M de Maat; Marieke J H A Kruip
Journal:  Haemophilia       Date:  2020-07-26       Impact factor: 4.287

3.  Hemophilia management: Huge impact of a tiny difference.

Authors:  Fabienne Kloosterman; Anne-Fleur Zwagemaker; Amal Abdi; Samantha Gouw; Giancarlo Castaman; Karin Fijnvandraat
Journal:  Res Pract Thromb Haemost       Date:  2020-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.